AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,870 | -16.1% | 45,500 | -31.9% | 0.00% | – |
| Q2 2023 | $61,815 | +280877.3% | 66,798 | +67.8% | 0.00% | – |
| Q1 2023 | $22 | -99.7% | 39,800 | +49.1% | 0.00% | – |
| Q3 2022 | $8,000 | -89.0% | 26,700 | -16.4% | 0.00% | – |
| Q4 2021 | $73,000 | -65.4% | 31,936 | -41.5% | 0.00% | – |
| Q2 2021 | $211,000 | -33.6% | 54,600 | -46.7% | 0.00% | – |
| Q1 2021 | $318,000 | +25.7% | 102,371 | +20.9% | 0.00% | – |
| Q4 2020 | $253,000 | +82.0% | 84,687 | +45.3% | 0.00% | – |
| Q3 2020 | $139,000 | -9.2% | 58,292 | +384.4% | 0.00% | – |
| Q2 2020 | $153,000 | -54.9% | 12,034 | -71.8% | 0.00% | – |
| Q1 2020 | $339,000 | -33.7% | 42,647 | -45.2% | 0.00% | – |
| Q4 2019 | $511,000 | +116.5% | 77,762 | +36.1% | 0.00% | – |
| Q3 2019 | $236,000 | -35.5% | 57,132 | -24.4% | 0.00% | – |
| Q2 2019 | $366,000 | -25.8% | 75,549 | +25.5% | 0.00% | -100.0% |
| Q1 2019 | $493,000 | +45.0% | 60,200 | -4.6% | 0.00% | +100.0% |
| Q4 2018 | $340,000 | – | 63,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |